Skip to main content
. Author manuscript; available in PMC: 2019 Sep 4.
Published in final edited form as: PM R. 2016 Jan 28;8(9):844–854. doi: 10.1016/j.pmrj.2016.01.010

Figure 3:

Figure 3:

AMSCs retained their proliferative capacity and metabolic function between days 1 and 4 post-injection, with no significant differences between injection groups. (A) DAPI assisted cell counts (values represent cells × 106) were similar among the three groups on days 1 and 4, and all groups demonstrated an exponential increase cell counts between days 1 and 4, reflecting maintenance of normal proliferative capacity. (B) MTS assay for mitochondrial activity revealed similar mitochondrial activity among the three treatment groups on days 1 and 4, as well a commensurate increase in mitochondrial activity between days 1 and 4. This latter finding reflects cell proliferation and corroborates the DAPI stain findings in (A).